If you've been looking into hair loss treatment, you've probably read about two of the heavyweights: finasteride and dutasteride. They work similarly. Both block DHT, the hormone responsible for male pattern hair loss. But they're not the same medication, and the differences matter clinically.

I'm Chris, a board-certified family nurse practitioner. I prescribe both. Here's how I think about them.

How they work

Both finasteride and dutasteride are 5-alpha reductase inhibitors. That means they block the enzyme that converts testosterone into DHT. DHT is what causes hair follicles to miniaturize over time in men with androgenetic alopecia.

The difference is how completely they block it.

Finasteride blocks one pathway, type 2 5-alpha reductase, and reduces serum DHT by approximately 70%. Dutasteride blocks both type 1 and type 2, reducing serum DHT by approximately 90 to 95%.1

More complete DHT suppression generally means better hair outcomes.

What the evidence shows

Finasteride 1mg is FDA-approved for male pattern hair loss and is the established first-line treatment. It works. In clinical trials it consistently outperforms placebo, stops progression in the majority of men, and promotes visible regrowth in around two-thirds of users.

Dutasteride 0.5mg is not FDA-approved for hair loss in the United States. It is approved for benign prostatic hyperplasia. Off-label prescribing is common and legal when supported by clinical evidence, and the evidence for dutasteride in AGA is compelling.

A randomized controlled trial of 917 patients found dutasteride 0.5mg was statistically superior to finasteride 1mg at increasing both hair count and hair width at 24 weeks.2

22
Average hair count increase per cm² with dutasteride at 24 weeks3
5.9
Average hair count increase per cm² with finasteride at 24 weeks3
30%
Greater improvement in hair count with dutasteride vs finasteride in phase 2 trials4

A 2025 head-to-head study found dutasteride produced an average increase of 22 hairs per cm² at 24 weeks, compared to 5.9 hairs per cm² for finasteride — nearly four times the improvement in the same timeframe.3

Phase 2 clinical data showed a 30% greater improvement in hair count with dutasteride 0.5mg compared to finasteride at five times the standard hair loss dose. Dutasteride at its approved dose outperformed finasteride even when finasteride was given at a much higher amount.4

A systematic meta-analysis confirmed these findings across multiple endpoints including hair count, investigator assessment, and patient-reported outcomes, with no significant difference in sexual side effects between the two medications.5

The evidence is consistent: dutasteride is more effective than finasteride for AGA. The gap between them is not marginal.

What to expect: onset and timeline

Both medications follow a similar timeline. Most men notice hair loss stabilization within 3 to 6 months. Visible regrowth, if it happens, typically becomes apparent around 12 months of consistent use.

Dutasteride's greater DHT suppression may produce more noticeable early results in some men, but the onset window is broadly the same for both medications. What differs is magnitude, not speed. At the same timepoints, dutasteride users tend to show significantly more hair than finasteride users. The clock starts at the same place.

Side effects

Sexual side effect profiles between the two medications are similar. The meta-analysis comparing head-to-head trials found no significant difference in rates of altered libido, erectile dysfunction, or ejaculation disorders between finasteride and dutasteride.5

Both carry the same PSA suppression concern. Finasteride reduces PSA by approximately 50%, dutasteride by a similar or greater amount. Tell your provider before any PSA screening is performed.

The fertility difference

This is where the two medications diverge most meaningfully for men of reproductive age.

Factor Finasteride Dutasteride
Half-life5 to 6 hours~5 weeks
Detectable after stoppingDays4 to 6 months
Sperm count effectPossible reductionPossible reduction
Recovery after stoppingRelatively fastSlower, variable
Recommended washout before conceptionDiscuss with providerMinimum 6 months

Finasteride has a mean terminal half-life of approximately 5 to 6 hours in most men. It clears your system relatively quickly after stopping.1

Dutasteride has a half-life of approximately 5 weeks. Serum concentrations remain detectable for up to 4 to 6 months after discontinuation. DHT suppression can persist well beyond the last dose.6

Both medications can reduce sperm count and semen volume. These effects appear to be reversible over time, but recovery timelines differ significantly between the two medications given dutasteride's longer half-life.

If you are planning to father a child in the near future, discuss timing with your provider before starting either medication. A minimum 6-month washout period is generally recommended for dutasteride before attempting conception.

So which one is right for you?

That depends on your clinical picture, your age, your response to prior treatment, and your family planning timeline. There is no one-size-fits-all answer.

Generally speaking, finasteride is an appropriate first-line choice for most men with AGA. Dutasteride may be considered for men who have not responded adequately to finasteride, or who want more aggressive DHT suppression from the start.

Ready to talk about treatment?

Complete a short intake form and I'll personally review your case within 24 hours. $50/month covers hair loss, ED, and PE.

Start Your Intake

Sources

  1. FDA. Propecia (finasteride) Prescribing Information. 2022. accessdata.fda.gov; Bhatt DK, et al. Finasteride. StatPearls. NCBI Bookshelf. Updated 2024. ncbi.nlm.nih.gov/books/NBK513329
  2. Olsen EA, et al. The importance of dual 5-alpha reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study comparing the efficacy and safety of dutasteride to finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023. PubMed PMID: 17097397.
  3. Comparative Study of Efficacy and Adverse Effect Profile of Oral Finasteride and Dutasteride in Male Androgenetic Alopecia. Journal of Contemporary Clinical Practice. 2025;11(6):791-801. jccpractice.com
  4. Gupta AK, et al. Relative Efficacy of Minoxidil and the 5-Alpha Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-Analysis. JAMA Dermatology. 2022;158(3):266-274. PubMed PMID: 35080596.
  5. Hu R, et al. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging. 2019;14:399-406. PMC6396621. pmc.ncbi.nlm.nih.gov/articles/PMC6396621
  6. Bhatt DK, et al. Dutasteride. StatPearls. NCBI Bookshelf. Updated 2024. ncbi.nlm.nih.gov; Zhou Z, et al. Dutasteride in the treatment of androgenetic alopecia. Journal of Dermatological Treatment. 2019;30(4):373-378. PubMed PMID: 30175650.